Abstract

In the UK, it is estimated that 1 in 10 patients admitted to hospital will develop a health care- associated infection; costing the NHS an estimated £1 billion per annum. Included in these figures are approximately 4% of surgical patients who develop a surgical-site infection, adding an average of 6.5 days to their hospital stay. Prophylactic antibiotics can reduce the risk of surgical-site infections. This contribution discusses the theory behind the use of prophylaxis, including adjuncts to standard intravenous regimens and the impact of antibiotic resistance.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.